Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibronectin-based masking molecule blocks platelet adhesion.

David H Geho1, William I Smith, Lance A Liotta

  • 1Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. gehod@mail.nih.gov

Bioconjugate Chemistry
|July 17, 2003
PubMed
Summary

This study developed a novel method to block platelet adhesion to damaged blood vessels. By modifying fibronectin with polyethylene glycol (PEG), researchers created a shield that prevents dangerous blood clot formation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fixed-Bed Bioreactor Culture Enhances Yield and Reparative Properties of hTERT Mesenchymal Stem Cell Extracellular Vesicles.

Cells·2026
Same author

Characterization of <i>Borrelia</i>-Derived Extracellular Vesicles: Implications for Pathogenesis and Diagnostics.

Microorganisms·2026
Same author

Laser capture microdissection.

Nature reviews. Methods primers·2026
Same author

Reproductive risk of Neonicotinoids: A review of male rodent studies.

Environmental research·2025
Same author

T Cell Activation Induces Synthesis of CD47 Proteoglycan Isoforms and Their Release in Extracellular Vesicles.

International journal of molecular sciences·2025
Same author

Secretory mitophagy: an extracellular vesicle-mediated adaptive mechanism for cancer cell survival under oxidative stress.

Frontiers in cell and developmental biology·2025

Area of Science:

  • Biomaterials Science
  • Vascular Biology
  • Biochemistry

Background:

  • Vessel wall extracellular matrix (ECM) promotes platelet adhesion and activation upon vascular injury.
  • Fibrillar collagens within the ECM are key thrombogenic components.
  • Vascular interventions like angioplasty and bypass grafting expose this matrix.

Purpose of the Study:

  • To develop a targeted strategy to block platelet adhesion to thrombogenic ECM molecules.
  • To create a molecular shielding reagent that selectively masks platelet-binding sites on ECM proteins.
  • To protect intact endothelium and other vascular proteins while preventing thrombosis.

Main Methods:

  • Selective pegylation of purified fibronectin (FN) with polyethylene glycol (PEG) moieties (5000 Da) to create FNPEG-5K.

Related Experiment Videos

  • Pegylation performed while FN was bound to a gelatin agarose matrix to preserve collagen-binding function.
  • Assessing the ability of FNPEG-5K to block platelet adhesion to purified type I collagen and vascular wall components.

    • Main Results:

    • FNPEG-5K effectively masked platelet-binding sites on fibronectin.
    • The modified fibronectin (FNPEG-5K) successfully blocked platelet adhesion to purified type I collagen.
    • FNPEG-5K also inhibited platelet adhesion to native vascular wall components, including collagens.

    Conclusions:

    • Targeted pegylation of fibronectin offers a promising approach for selective blockade of platelet adhesion to ECM.
    • This strategy has potential applications in preventing thrombosis associated with vascular interventions.
    • The method preserves the function of other vascular proteins and intact endothelium.